Clinical Trial Update: Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase II clinical trial update evaluating the combination of paclitaxel poliglumex and pemetrexed (Alimta) in advanced non-small cell lung cancer, with the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Paclitaxel poliglumex (paclitaxel poliglumex)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Advanced Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-01-09